Table II.
SUCRA of SLE treatments.
| Treatment | SUCRA (%) | Pr Best | Mean Rank |
|---|---|---|---|
| Belimumab | 75 | 20.9 | 2.5 |
| Epratuzumab | 62 | 17.2 | 3.3 |
| Tabalumab | 57.1 | 13.1 | 3.6 |
| Atacicept | 55.1 | 24.1 | 3.7 |
| Rituximab | 52.6 | 21.7 | 3.8 |
| Blisibimod | 29.4 | 3 | 5.2 |
| Placebo | 18.7 | 0 | 5.9 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.